A ‘liquid biopsy’ blood test for colorectal cancer recurrence has earned its founders the 2017 Johnson & Johnson Eureka Prize for Innovation in Medical Research. The award for Colvera™, a circulating tumour DNA test that detects methylated DNA from the BCAT1 and IKZF1 genes, went to biotech company Clinical Genomics and partners, the CSIRO and Flinders University. ...
EUREKA moment for bowel cancer detection
By Mardi Chapman
6 Sep 2017